Year |
Citation |
Score |
2022 |
Shalom B, Farago M, Salaymeh Y, Sebban S, Pikarsky E, Katzav S. Vav1 Promotes B-Cell Lymphoma Development. Cells. 11. PMID 35326399 DOI: 10.3390/cells11060949 |
0.318 |
|
2018 |
Shalom B, Farago M, Pikarsky E, Katzav S. Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes. Oncogenesis. 7: 80. PMID 30297765 DOI: 10.1038/s41389-018-0091-1 |
0.303 |
|
2014 |
Sebban S, Farago M, Rabinovich S, Lazer G, Idelchuck Y, Ilan L, Pikarsky E, Katzav S. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion. Oncotarget. 5: 9214-26. PMID 25313137 DOI: 10.18632/oncotarget.2400 |
0.347 |
|
2010 |
Lazer G, Pe'er L, Farago M, Machida K, Mayer BJ, Katzav S. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity. The Journal of Biological Chemistry. 285: 23075-85. PMID 20457609 DOI: 10.1074/Jbc.M109.094508 |
0.319 |
|
2006 |
Schlezinger JJ, Liu D, Farago M, Seldin DC, Belguise K, Sonenshein GE, Sherr DH. A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biological Chemistry. 387: 1175-87. PMID 16972784 DOI: 10.1515/Bc.2006.145 |
0.588 |
|
2005 |
Seldin DC, Landesman-Bollag E, Farago M, Currier N, Lou D, Dominguez I. CK2 as a positive regulator of Wnt signalling and tumourigenesis. Molecular and Cellular Biochemistry. 274: 63-7. PMID 16342409 DOI: 10.1007/S11010-005-3078-0 |
0.453 |
|
2005 |
Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao ZX, Sherr DH, Seldin DC. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicologic Pathology. 33: 726-37. PMID 16263698 DOI: 10.1080/01926230500352226 |
0.637 |
|
2005 |
Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Research. 65: 5792-801. PMID 15994955 DOI: 10.1158/0008-5472.Can-05-1021 |
0.757 |
|
Show low-probability matches. |